DT.REAL ESTATE AG O.N./ DE0008055021 /
6/16/2025 11:02:39 AM | Chg. - | Volume | Bid9:02:06 AM | Ask9:02:06 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
5.9000EUR | - | 3 Turnover: 17.7000 |
5.9000Bid Size: 0 | 5.9500Ask Size: 0 | 121.43 mill.EUR | - | 5.73 |
Newsfile Corp
1:30 PM
MAX Power Team Identifies Rare Basement Source Rocks as Potential Natural Hydrogen Source
Newsfile Corp
1:30 PM
Silver47 Exploration Launches Drilling to Expand Silver-Rich VMS Deposits at Red Mountain, Alaska
GlobeNewswire
1:00 PM
Eccogene Announces First Patient Dosed in Phase 1b Trial of AZD5004/ECC5004, a Novel Oral GLP-1 Rece...
GlobeNewswire
1:00 PM
3D Systems Announces Issuance of $92 Million of Convertible Senior Secured Notes due 2030 and Retire...
GlobeNewswire
1:00 PM
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Ca...
GlobeNewswire
1:00 PM
BPGbio Announces Presentation of Preliminary Clinical Data of Investigational BPM31510 for Primary C...
GlobeNewswire
1:00 PM
Sharps Technology Advances Shipment Under $50 Million SoloGard Supply Agreement and Begins Manufactu...
GlobeNewswire
1:00 PM
Axsome Therapeutics to Present Data Spanning the SYMBRAVO® (meloxicam and rizatriptan) Clinical Prog...
GlobeNewswire
1:00 PM
Extensive Greenland Lithium Exploration Campaign Launched by Brunswick Exploration
GlobeNewswire
1:00 PM
Simply Good Foods to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, July 10, 2...
GlobeNewswire
1:00 PM
Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Pa...
GlobeNewswire
1:00 PM
Rafael Holdings Announces Continuation of its Phase 3 Study for the Treatment of Niemann-Pick Diseas...
GlobeNewswire
1:00 PM
Miguel Ángel Jiménez Signs with Newton Golf Company Following Tour Win Using Newton Fast Motion Shaf...
GlobeNewswire
1:00 PM
Senti Bio Granted U.S. FDA Orphan Drug Designation for Use of First-in-Class Off-the-Shelf Logic Gat...
GlobeNewswire
1:00 PM
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from ...